Aligos Therapeutics, Inc.

NasdaqCM:ALGS Stock Report

Market Cap: US$62.3m

Aligos Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqCM:ALGS Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
25 Oct 23BuyUS$6,004,149Roche Holding AGCompany7,933,601US$0.76

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of ALGS?
Owner TypeNumber of SharesOwnership Percentage
Private Companies18,7280.0248%
Individual Insiders4,267,6815.64%
VC/PE Firms6,102,7708.07%
Public Companies11,025,94114.6%
General Public12,150,80216.1%
Hedge Funds14,478,97019.1%
Institutions27,623,62936.5%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 76.2%.


Top Shareholders

Top 25 shareholders own 83.2% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
14.6%
Roche Holding AG
11,025,941US$9.1m257%no data
9.6%
EcoR1 Capital, LLC
7,264,147US$6.0m84%0.18%
9.53%
Armistice Capital LLC
7,214,823US$5.9m0%0.15%
8.07%
Deep Track Capital, LP
6,102,770US$5.0m0%0.16%
4.84%
Baker Bros. Advisors LP
3,664,013US$3.0m-29.1%0.04%
4.69%
Vivo Capital, LLC
3,547,030US$2.9m0%0.22%
3.81%
Alyeska Investment Group, L.P.
2,882,216US$2.4m0%0.01%
3.76%
Altitude Crest Partners Inc.
2,844,681US$2.3m0%1.71%
3.07%
Versant Venture Management, LLC
2,320,381US$1.9m0%0.53%
2.89%
Tang Capital Management, LLC
2,189,847US$1.8m-34.2%0.19%
2.8%
Lawrence Blatt
2,120,633US$1.7m40.4%no data
2.52%
Hillhouse Investment Management, Ltd.
1,906,191US$1.6m-17.5%0.01%
2%
Leonid Beigelman
1,510,352US$1.2m0%no data
1.71%
Opaleye Management Inc.
1,297,000US$1.1m0%0.25%
1.66%
Newtyn Management, LLC
1,255,000US$1.0m36.4%0.12%
1.52%
Bank of America Corporation, Asset Management Arm
1,147,762US$945.3k-0.21%no data
1.34%
The Vanguard Group, Inc.
1,011,651US$833.2k0.1%no data
0.98%
Pivotal BioVenture Partners LLC
743,215US$612.1k0%0.23%
0.88%
Silverarc Capital Management, LLC
668,512US$550.6k5.8%0.15%
0.74%
Acadian Asset Management LLC
559,367US$460.7k-0.95%no data
0.65%
Renaissance Technologies LLC
489,960US$403.5k52.5%no data
0.52%
Julian Symons
394,064US$324.6k0%no data
0.42%
Geode Capital Management, LLC
321,044US$264.4k32.9%no data
0.39%
BlackRock, Inc.
296,139US$243.9k-0.28%no data
0.24%
James Scopa
183,083US$150.8k0%no data
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.